comparemela.com

Latest Breaking News On - Justin keywood - Page 6 : comparemela.com

ATS Automation is a Buy, says Stifel

Stifel GMP analyst Justin Keywood in a Monday note resumed coverage of ATS Automation with a Buy rating and reiterated a target of $75.00, saying a record backlog, M&A potential and skin in the electric vehicle game are all positives for ATS.

United kingdomJustin keywoodStock quote

Friday s analyst upgrades and downgrades - The Globe and Mail

Inside the Market’s roundup of some of today’s key analyst actions

British columbiaUnited statesJefferie randy konickCowen john kernanCanaccord genuity katie lachapelleBryce adamsMarketr waqar syedJefferie randal konikBrian morrisonKeybanc noah zatzkinRaymond jame steve hansenCamino rojoBarclay adrienne yihGreg barnesStifel justin keywoodAsia pacific

Monday s TSX breakouts: With a recent NYSE listing, this Canadian industrials stock flirts with a record high

This outperformer isn’t cheap

United statesUnited kingdomRaymond jamesStifel justin keywoodToronto stock exchangeNew york stock exchangeGoldman sachsYork stock exchangeAutomation tooling systems incNational bank maxim sytchevNational bank financialAutomation tooling systemsNew york stockNorth americaSoutheast asiaCormark securities

WELL Health is heading higher, says Stifel

Stifel GMP analyst Justin Keywood in a Thursday report reiterated a “Buy” rating and $13.50 target price on WELL Health Technologies.

British columbiaUnited statesJayson macleanJustin keywoodHamed shahbaziNick waddellHealth technologies stockHealth technologiesTechnologies stock quoteCircle medicalForward sales

Wednesday s analyst upgrades and downgrades - The Globe and Mail

Inside the Market’s roundup of some of today’s key analyst actions

United kingdomUnited statesNova scotiaDavid chrystalMichael doumetGregory renzaTom callaghanSohrab movahediKiran sritharanGraham rydingTom mackinnonTom narayanJoel jacksonFrank takkinenJefferie suji jeongHani kaissi

vimarsana © 2020. All Rights Reserved.